Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-25-000968
Filing Date
2025-02-11
Accepted
2025-02-11 20:51:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9754
2 d11603144_ex99-a.htm EX-99 4389
3 d11603144_ex99-b.htm EX-99 773
  Complete submission text file 0000919574-25-000968.txt   16706
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

EIN.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076
Business Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076 49 7071 5397 700
Immatics N.V. (Subject) CIK: 0001809196 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91607 | Film No.: 25611594
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)